School of Medicine

Wayne State University School of Medicine

Acorda DER Oral pill to improve muscle endurance and walking - Closed to Enrollment

This study is a 6 week multi-center study to evaluate the safety and effectiveness of two doses of oral dalfampridine extended release tablets in patients with Multiple Sclerosis (MS). Patient will be randomly assigned to receive 5mg dalfampridine, 10 mg dalfampridine, or placebo (dummy pill).

 
Eligibility: Patients 18-70 years old with MS who have difficulties walking.
For more information visit: Acorda DER